Advertisement
Screener

GILEAD SCIENCES, INC. (GILD) Auditor

GILEAD SCIENCES, INC. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-02-24: Fiscal year end 2025-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location San Mateo, California.
  • 2025-02-28: Fiscal year end 2024-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location San Mateo, California.
  • 2024-02-23: Fiscal year end 2023-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location San Mateo, California.
  • 2023-02-22: Fiscal year end 2022-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location San Jose, California.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-02-242025-12-31Ernst & Young LLP42San Mateo, CaliforniaYes
2025-02-282024-12-31Ernst & Young LLP42San Mateo, CaliforniaYes
2024-02-232023-12-31Ernst & Young LLP42San Mateo, CaliforniaYes
2023-02-222022-12-31Ernst & Young LLP42San Jose, CaliforniaYes
2022-02-232021-12-31Ernst & Young LLP42San Jose, CaliforniaYes
2021-02-252020-12-31Ernst & Young LLPSan Jose, CaliforniaYes
2020-02-252019-12-31Ernst & Young LLPSan Jose, California
2019-02-262018-12-31Ernst & Young LLPSan Jose, California
2018-02-272017-12-31Ernst & Young LLPRedwood City, California
2017-02-272016-12-31ERNST & YOUNG LLPRedwood City, California
2016-02-242015-12-31ERNST & YOUNG LLPRedwood City, California
2015-02-252014-12-31ERNST & YOUNG LLPRedwood City, California
2014-02-252013-12-31ERNST & YOUNG LLPRedwood City, California
2013-02-272012-12-31ERNST & YOUNG LLPRedwood City, California
2012-02-232011-12-31ERNST & YOUNG LLPRedwood City, California
2011-02-282010-12-31ERNST & YOUNG LLPPalo Alto, California
2010-03-012009-12-31ERNST & YOUNG LLPPalo Alto, California
2009-02-272008-12-31ERNST & YOUNG LLPPalo Alto, California

Similar stocks

Stock NameCountryMarket CapPE Ratio
AMGEN INC (AMGN)United States$219.567B22.39
Moderna, Inc. (MRNA)United States$77.819B-8.86
Revolution Medicines, Inc. (RVMD)United States$42.805B-22.69
BIOGEN INC. (BIIB)United States$33.427B19.60
EXELIXIS, INC. (EXEL)United States$14.358B16.15
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31